CoChat

Role for mTOR Signaling and Neuronal Activity in Morphine-Induced Adaptations in Ventral Tegmental Area Dopamine Neurons

Open access
Mazei-Robison, Michelle S., Koo, Ja Wook, Friedman, Allyson K., Lansink, Carien S., Robison, Alfred J., Vinish, Monika, Krishnan, Vaishnav, Kim, Seyun, Siuta, Michael A., Galli, Aurelio, Niswender, Kevin D., Appasani, Raghu, Horvath, Monika C., Neve, Rachel L., Worley, Paul F., Snyder, Solomon H., Hurd, Yasmin L., Cheer, Joseph F., Han, Ming-Hu, Russo, Scott J., Nestler, Eric J. · 2011 · Neuron
Cited by 143

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

SUMMARY While the abuse of opiate drugs continues to rise, the neuroadaptations that occur with long-term drug exposure remain poorly understood. We describe here a series of chronic morphine-induced adaptations in ventral tegmental area (VTA) dopamine neurons, which are mediated via downregulation of AKT-mTORC2 (mammalian target of rapamycin complex-2). Chronic opiates decrease the size of VTA dopamine neurons in rodents, an effect seen in humans as well, and concomitantly increase the excitability of the cells but decrease dopamine output to target regions. Chronic morphine decreases mTORC2 activity, and overexpression of Rictor, a component of mTORC2, prevents morphine-induced changes in cell morphology and activity. Further, local knock-out of Rictor in VTA decreases DA soma size and reduces rewarding responses to morphine, consistent with the hypothesis that these adaptations represent a mechanism of reward tolerance. Together, these findings demonstrate a novel role for AKT-mTORC2 signaling in mediating neuroadaptations to opiate drugs of abuse.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2011.10.012

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. Beitner-Johnson, 1993, Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system, Neuroreport, 5, 57, 10.1097/00001756-199310000-00014 · DOI
  2. Beitner-Johnson, 1992, Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area, J. Neurosci., 12, 2165, 10.1523/JNEUROSCI.12-06-02165.1992 · DOI · Paper page
  3. Boulbes, 2010, Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2, Mol. Cancer Res., 8, 896, 10.1158/1541-7786.MCR-09-0409 · DOI · Paper page
  4. Cao, 2010, Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons, Proc. Natl. Acad. Sci. USA, 107, 17011, 10.1073/pnas.1010077107 · DOI · Paper page
  5. Chen, 2001, Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene, Genes Dev., 15, 2203, 10.1101/gad.913901 · DOI · Paper page
  6. Chu, 2007, Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats, Brain Res., 1182, 90, 10.1016/j.brainres.2007.08.086 · DOI
  7. Diana, 1995, Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats, J. Pharmacol. Exp. Ther., 272, 781, 10.1016/S0022-3565(25)24484-6 · DOI · Paper page
  8. Dibble, 2009, Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1, Mol. Cell. Biol., 29, 5657, 10.1128/MCB.00735-09 · DOI · Paper page
  9. Easton, 2005, Role for Akt3/protein kinase Bgamma in attainment of normal brain size, Mol. Cell. Biol., 25, 1869, 10.1128/MCB.25.5.1869-1878.2005 · DOI · Paper page
  10. Fischer, 2008, Morphine blood levels, dependence, and regulation of hippocampal subgranular zone proliferation rely on administration paradigm, Neuroscience, 151, 1217, 10.1016/j.neuroscience.2007.11.035 · DOI
  11. Foster, 2010, Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony, J. Biol. Chem., 285, 14071, 10.1074/jbc.R109.094003 · DOI · Paper page
  12. Georges, 2006, No effect of morphine on ventral tegmental dopamine neurons during withdrawal, J. Neurosci., 26, 5720, 10.1523/JNEUROSCI.5032-05.2006 · DOI · Paper page
  13. Hoeffer, 2010, mTOR signaling: at the crossroads of plasticity, memory and disease, Trends Neurosci., 33, 67, 10.1016/j.tins.2009.11.003 · DOI · Paper page
  14. Hoeffer, 2008, Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior, Neuron, 60, 832, 10.1016/j.neuron.2008.09.037 · DOI · Paper page
  15. Horvath, 2007, Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age, J. Neurosci., 27, 13371, 10.1523/JNEUROSCI.2398-07.2007 · DOI
  16. Hu, 2009, Electroacupuncture treatment reverses morphine-induced physiological changes in dopaminergic neurons within the ventral tegmental area, Addict. Biol., 14, 431, 10.1111/j.1369-1600.2009.00163.x · DOI
  17. Hyman, 2006, Neural mechanisms of addiction: the role of reward-related learning and memory, Annu. Rev. Neurosci., 29, 565, 10.1146/annurev.neuro.29.051605.113009 · DOI · Paper page
  18. Julien, 2010, mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling, Mol. Cell. Biol., 30, 908, 10.1128/MCB.00601-09 · DOI · Paper page
  19. Kwon, 2003, mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo, Proc. Natl. Acad. Sci. USA, 100, 12923, 10.1073/pnas.2132711100 · DOI · Paper page
  20. Laplante, 2009, mTOR signaling at a glance, J. Cell Sci., 122, 3589, 10.1242/jcs.051011 · DOI · Paper page
  21. McClung, 2005, Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area, J. Neurosci., 25, 6005, 10.1523/JNEUROSCI.0062-05.2005 · DOI · Paper page
  22. Oh, 2011, mTOR complex 2 signaling and functions, Cell Cycle, 10, 2305, 10.4161/cc.10.14.16586 · DOI · Paper page
  23. Partovian, 2008, Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells, Mol. Cell, 32, 140, 10.1016/j.molcel.2008.09.010 · DOI · Paper page
  24. Rossetti, 1992, Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats, Eur. J. Pharmacol., 221, 227, 10.1016/0014-2999(92)90706-A · DOI · Paper page
  25. Rossetti, 1992, Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence, Ann. N Y Acad. Sci., 654, 513, 10.1111/j.1749-6632.1992.tb26016.x · DOI
  26. Russo, 2007, IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates, Nat. Neurosci., 10, 93, 10.1038/nn1812 · DOI · Paper page
  27. Sarbassov, 2005, Growing roles for the mTOR pathway, Curr. Opin. Cell Biol., 17, 596, 10.1016/j.ceb.2005.09.009 · DOI · Paper page
  28. Shah, 2004, Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies, Curr. Biol., 14, 1650, 10.1016/j.cub.2004.08.026 · DOI · Paper page
  29. Shiota, 2006, Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability, Dev. Cell, 11, 583, 10.1016/j.devcel.2006.08.013 · DOI · Paper page
  30. Siuta, 2010, Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice, PLoS Biol., 8, e1000393, 10.1371/journal.pbio.1000393 · DOI · Paper page
  31. Sklair-Tavron, 1996, Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons, Proc. Natl. Acad. Sci. USA, 93, 11202, 10.1073/pnas.93.20.11202 · DOI · Paper page
  32. Spiga, 2010, Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence, Addict. Biol., 15, 266, 10.1111/j.1369-1600.2010.00218.x · DOI
  33. Spiga, 2003, Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy, Eur. J. Neurosci., 17, 605, 10.1046/j.1460-9568.2003.02435.x · DOI · Paper page
  34. Treins, 2010, Rictor is a novel target of p70 S6 kinase-1, Oncogene, 29, 1003, 10.1038/onc.2009.401 · DOI
  35. van Diepen, 2009, MyosinV controls PTEN function and neuronal cell size, Nat. Cell Biol., 11, 1191, 10.1038/ncb1961 · DOI · Paper page
  36. Wang, 2003, Control of synaptic strength, a novel function of Akt, Neuron, 38, 915, 10.1016/S0896-6273(03)00356-8 · DOI · Paper page
  37. Wolf, 1999, Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration, J. Neurochem., 73, 1520, 10.1046/j.1471-4159.1999.0731520.x · DOI · Paper page

Cited by

See all 143

Metadata

Authors
Mazei-Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M. A., Galli, A., Niswender, K. D., Appasani, R., Horvath, M. C., Neve, R. L., Worley, P. F., Snyder, S. H., Hurd, Y. L., Cheer, J. F., Han, M.-H., Russo, S. J., & Nestler, E. J.
Venue
Neuron
Publisher
Elsevier BV
Published
2011-12
Volume
72
Issue
6
Pages
977-990
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2009097612
Cited by
143
References
17
FWCI
3.57
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.